Magnetic Seed vs Guidewire Breast Cancer Localization With Magnetic Lymph Node Detection
JAMA Surgery · 01.03.2024 · 159 (3) · 239
DOI: 10.1001/jamasurg.2023.6520 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.03.2024. Verfasst von Eirini Pantiora und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Breast Neoplasms, Ferric Compounds. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Guidewires have been the standard for breast lesion localization but pose operative and logistic challenges. Paramagnetic seeds have shown promising results, but to the authors’ knowledge, no randomized comparison has been performed.
Objective
To determine whether the combination of a paramagnetic seed and superparamagnetic iron oxide (SPIO) is equivalent to guidewire and SPIO for breast cancer localization and sentinel lymph node detection (SLND). Design, Setting, and Participants This was a phase 3, pragmatic, equivalence, 2-arm, open-label, randomized clinical trial conducted at 3 university and/or community hospitals in Sweden from May 2018 to May 2022. Included in the study were patients with early breast cancer planned for breast conservation and SLND. Study data were analyzed July to November 2022.
Interventions
Participants were randomly assigned 1:1 to a paramagnetic seed or a guidewire. All patients underwent SLND with SPIO. Main Outcomes and Measures Re-excision rate and resection ratio (defined as actual resection volume / optimal resection volume).
Results
A total of 426 women (median [IQR] age, 65 [56-71] years; median [IQR] tumor size, 11 [8-15] mm) were included in the study. The re-excision rate was 2.90% (95% CI, 1.60%-4.80%), and the median (IQR) resection ratio was 1.96 (1.15-3.44). No differences were found between the guidewire and the seed in re-excisions (6 of 211 [2.84%] vs 6 of 209 [2.87%]; difference, −0.03%; 95% CI, −3.20% to 3.20%; P = .99) or resection ratio (median, 1.93; IQR, 1.18-3.43 vs median, 2.01; IQR, 1.11-3.47; P = .70). Overall SLN detection was 98.6% (95% CI, 97.1%-99.4%) with no differences between arms (203 of 207 [98.1%] vs 204 of 206 [99.0%]; difference, −0.9%; 95% CI, −3.6% to 1.8%; P = .72). More failed localizations occurred with the guidewire (21 of 208 [10.1%] vs 4 of 215 [1.9%]; difference, 8.2%; 95% CI, 3.3%-13.2%; P < .001). Median (IQR) time to specimen excision was shorter for the seed (15 [10-22] minutes vs 18 [12-30] minutes; P = .01), as was the total operative time (69 [56-86] minutes vs 75.5 [59-101] minutes; P = .03). The experience of surgeons, radiologists, and surgical coordinators was better with the seed. Conclusions and Relevance The combination of SPIO and a paramagnetic seed performed comparably with SPIO and guidewire for breast cancer conserving surgery and resulted in more successful localizations, shorter operative times, and better experience. Trial Registration ISRCTN.org Identifier: ISRCTN11914537
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Section for Breast Surgery, Department of Surgery, Uppsala University Hospital, Uppsala, Sweden.
- Center for Clinical Research, Department of Surgical Sciences, Uppsala University, Västerås, Sweden.
- Section for Breast Surgery, Department of Surgery, Västmanlands County Hospital, Västerås, Sweden.
- Evidia Mammography Department, Uppsala, Sweden.
- Department of Breast Radiology, Division of Radiology, Västmanlands County Hospital, Västerås, Sweden.
Zitieren
APA
Pantiora, E., Jazrawi, A., Hersi, A. F., Abdsaleh, S., Ahlstedt, H., Molnar, E., Wärnberg, F., Eriksson, S., & Karakatsanis, A. (2024). Magnetic Seed vs Guidewire Breast Cancer Localization With Magnetic Lymph Node Detection. JAMA Surgery, 159(3), 239. https://doi.org/10.1001/jamasurg.2023.6520
Vancouver
Pantiora E, Jazrawi A, Hersi AF, Abdsaleh S, Ahlstedt H, Molnar E, et al. Magnetic Seed vs Guidewire Breast Cancer Localization With Magnetic Lymph Node Detection. JAMA Surgery. 2024;159(3):239. doi:10.1001/jamasurg.2023.6520
BibTeX
@article{Pantiora2024,
author = {Pantiora, Eirini and Jazrawi, Allan and Hersi, Abdi-Fatah and Abdsaleh, Shahin and Ahlstedt, Hanna and Molnar, Eva and Wärnberg, Fredrik and Eriksson, Staffan and Karakatsanis, Andreas},
title = {Magnetic Seed vs Guidewire Breast Cancer Localization With Magnetic Lymph Node Detection},
journal = {JAMA Surgery},
year = {2024},
volume = {159},
number = {3},
pages = {239},
doi = {10.1001/jamasurg.2023.6520}
}
EUVIMED